Abera Bioscience Balance Sheet Health
Financial Health criteria checks 3/6
Abera Bioscience has a total shareholder equity of SEK8.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK11.1M and SEK2.3M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 2.63m |
| Equity | SEK 8.80m |
| Total liabilities | SEK 2.30m |
| Total assets | SEK 11.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8WK's short term assets (SEK8.8M) exceed its short term liabilities (SEK2.3M).
Long Term Liabilities: 8WK's short term assets (SEK8.8M) do not cover its long term liabilities (SEK-1,000.0).
Debt to Equity History and Analysis
Debt Level: 8WK is debt free.
Reducing Debt: 8WK has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8WK has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 8WK has less than a year of cash runway if free cash flow continues to reduce at historical rates of 32.2% each year